EGFR Targeted Paclitaxel and Piperine Co-loaded Liposomes for the Treatment of Triple Negative Breast Cancer.

Burande AS, Viswanadh MK, Jha A, Mehata AK, Shaik A, Agrawal N, Poddar S, Mahto SK, Muthu MS

Open source

DOI
10.1208/s12249-020-01671-7
Published
2020 May 21
Container
AAPS PharmSciTech
Publisher
Not recorded
Open access
unknown

Credibility signals

serious concern Score 2/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1208/s12249-020-01671-7,
  title = {EGFR Targeted Paclitaxel and Piperine Co-loaded Liposomes for the Treatment of Triple Negative Breast Cancer.},
  author = {Burande AS and Viswanadh MK and Jha A and Mehata AK and Shaik A and Agrawal N and Poddar S and Mahto SK and Muthu MS},
  year = {2020},
  journal = {AAPS PharmSciTech},
  doi = {10.1208/s12249-020-01671-7},
  url = {https://doi.org/10.1208/s12249-020-01671-7}
}

RIS

TY  - JOUR
TI  - EGFR Targeted Paclitaxel and Piperine Co-loaded Liposomes for the Treatment of Triple Negative Breast Cancer.
AU  - Burande AS
AU  - Viswanadh MK
AU  - Jha A
AU  - Mehata AK
AU  - Shaik A
AU  - Agrawal N
AU  - Poddar S
AU  - Mahto SK
AU  - Muthu MS
PY  - 2020
JO  - AAPS PharmSciTech
DO  - 10.1208/s12249-020-01671-7
UR  - https://doi.org/10.1208/s12249-020-01671-7
ER  - 

APA

AS, B., MK, V., A, J., AK, M., A, S., N, A., S, P., SK, M., & MS, M. (2020). EGFR Targeted Paclitaxel and Piperine Co-loaded Liposomes for the Treatment of Triple Negative Breast Cancer.. AAPS PharmSciTech. https://doi.org/10.1208/s12249-020-01671-7

Source records